These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10573144)

  • 1. Coexisting myelodysplasia and myeloproliferative features in a single clone containing 5q-, Ph and i(17q).
    Garay CA; Al-Saleem T; Testa JR; Smith MR
    Leuk Res; 1999 Oct; 23(10):965-7. PubMed ID: 10573144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5q- syndrome presenting chronic myeloproliferative disorders-like manifestation: a case report.
    Takahashi H; Furukawa T; Hashimoto S; Kanazawa N; Satoh N; Suzuki N; Takizawa J; Uesugi Y; Takahashi M; Aizawa Y; Koike T
    Am J Hematol; 2000 Jun; 64(2):120-3. PubMed ID: 10814992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Philadelphia chromosome and 5q- in secondary blood disorder.
    Dastugue N; Demur C; Pris F; Bugat R; Attal M; Bourrouillou G; Colombies P
    Cancer Genet Cytogenet; 1988 Feb; 30(2):253-9. PubMed ID: 3422579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5q-, twenty-five years later: a synopsis.
    Van den Berghe H; Michaux L
    Cancer Genet Cytogenet; 1997 Mar; 94(1):1-7. PubMed ID: 9078284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders?
    Koike T; Uesugi Y; Toba K; Narita M; Fuse I; Takahashi M; Shibata A
    Leukemia; 1995 Mar; 9(3):517-8. PubMed ID: 7885050
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence of BCR-ABL rearrangement in a Philadelphia chromosome-negative patient with 5q and 13q deletions and myeloproliferative syndrome.
    Villegas A; Anguita E; González FA; Ferro MT; San Román C
    Cancer Genet Cytogenet; 1998 Jan; 100(1):1-4. PubMed ID: 9406572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two karyotypically unrelated clones with the t(5;17) and deletion of 5q in myelodysplastic syndrome.
    Novak A; Jankovic G; Rolovic Z
    Cancer Genet Cytogenet; 1992 Aug; 62(1):100-2. PubMed ID: 1521224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDS with del(5q) and associated cKIT D816V positive mastocytosis.
    Chan N; Tan SY; Opat S; Shortt J
    Pathology; 2012 Aug; 44(5):492-3. PubMed ID: 22777071
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Late appearing Philadelphia chromosome as another clone in a patient with myelodysplastic syndrome harboring der(5;12)(q10;q10) at diagnosis].
    Manabe M; Yoshii Y; Mukai S; Sakamoto E; Kanashima H; Nakao T; Kubo Y; Fukushima H; Inoue T; Yamane T; Teshima H
    Rinsho Ketsueki; 2012 Jun; 53(6):618-22. PubMed ID: 22790637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous remission of anemia associated with a myelodysplastic syndrome with disease evolution into a myeloproliferative state.
    Tefferi A; Inwards DJ; Hoyer JD
    Acta Haematol; 1999 Mar; 101(1):50-2. PubMed ID: 10085439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of single chromosome abnormalities in preleukemic states.
    Nowell PC; Besa EC
    Cancer Genet Cytogenet; 1989 Oct; 42(1):1-7. PubMed ID: 2790739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent genetic defects on chromosome 5q in myeloid neoplasms.
    Hosono N; Makishima H; Mahfouz R; Przychodzen B; Yoshida K; Jerez A; LaFramboise T; Polprasert C; Clemente MJ; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Sanada M; Cui E; Verma AK; McDevitt MA; List AF; Saunthararajah Y; Sekeres MA; Boultwood J; Ogawa S; Maciejewski JP
    Oncotarget; 2017 Jan; 8(4):6483-6495. PubMed ID: 28031539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated isochromosome 17q: a distinct type of mixed myeloproliferative disorder/myelodysplastic syndrome with an aggressive clinical course.
    McClure RF; Dewald GW; Hoyer JD; Hanson CA
    Br J Haematol; 1999 Aug; 106(2):445-54. PubMed ID: 10460605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5q- syndrome in a child with slowly progressive pancytopenia: a case report and review of the literature.
    Pitman SD; Victorio A; Rowsell E; Morris J; Wang J
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):115-9. PubMed ID: 16679931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis.
    Terpos E; Verrou E; Banti A; Kaloutsi V; Lazaridou A; Zervas K
    Leuk Res; 2007 Apr; 31(4):559-62. PubMed ID: 16820206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Report of two cases and review of the literature.
    Verhoef G; Meeus P; Stul M; Mecucci C; Cassiman JJ; Van Den Berghe H; Boogaerts M
    Cancer Genet Cytogenet; 1992 Apr; 59(2):161-6. PubMed ID: 1581881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myelodysplastic syndrome with chromosome 5q deletion and philadelphia chromosome: case report and literatures review].
    Zhang YQ; Liu RT; Pan JQ; Xu P; Li XY; Yu LQ; Gao HY; Jiang YF
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):940-942. PubMed ID: 33333699
    [No Abstract]   [Full Text] [Related]  

  • 19. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta.
    Steer EJ; Cross NC
    Acta Haematol; 2002; 107(2):113-22. PubMed ID: 11919393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.